ArticleWorld journal of gastrointestinal oncology2018

Multicenter phase II trial of modified FOLFIRINOX in gemcitabine-refractory pancreatic cancer.

Moon Jae Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.